awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q31158500-90613E33-3B45-4529-A4A4-43BF933108E5
Q31158500-90613E33-3B45-4529-A4A4-43BF933108E5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31158500-90613E33-3B45-4529-A4A4-43BF933108E5
Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials.
P2860
Q31158500-90613E33-3B45-4529-A4A4-43BF933108E5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31158500-90613E33-3B45-4529-A4A4-43BF933108E5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
43006d3082d9e04880cf68a9d4f3e4d01745c5ca
P2860
Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease.